Cabio Biotech (Wuhan) Co., Ltd.

SHSE:688089 株式レポート

時価総額:CN¥3.5b

Cabio Biotech (Wuhan) マネジメント

マネジメント 基準チェック /34

Cabio Biotech (Wuhan)の CEO はDewei Yiで、 Dec2015年に任命され、 の在任期間は 8.92年です。 は、会社の株式の1.39%を直接所有しており、その価値はCN¥ 48.35M 。経営陣と取締役会の平均在任期間はそれぞれ8.9年と5.9年です。

主要情報

Dewei Yi

最高経営責任者

CN¥1.1m

報酬総額

CEO給与比率n/a
CEO在任期間8.9yrs
CEOの所有権1.4%
経営陣の平均在職期間8.9yrs
取締役会の平均在任期間5.9yrs

経営陣の近況

Recent updates

We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Nov 04
We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Oct 28
Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

Oct 01
Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Aug 06
There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Jun 07
Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

May 06
Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

May 03
Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

Mar 21
The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

CEO(最高経営責任者

Dewei Yi (59 yo)

8.9yrs

在職期間

CN¥1,090,600

報酬

Mr. Dewei Yi is Chairman and General Manager of CABIO Biotech(Wuhan) Co., Ltd., since December 2015. From December 1999 he has been the chairman of Wuhan Xiwang Biological Engineering Co., Ltd.; since Nove...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Dewei Yi
Chairman & GM8.9yrsCN¥1.09m1.39%
CN¥ 48.4m
Huabiao Wang
Financial Director & Director8.9yrsCN¥781.40k0.66%
CN¥ 23.0m
Huarong Yi
Deputy GM & Secretary of the Board of Directorsno dataCN¥640.10k0.089%
CN¥ 3.1m
Anfeng Geng
Deputy General Manager3.7yrsCN¥713.40k0.098%
CN¥ 3.4m
Zhiming Wang
Deputy General Manager2.9yrsCN¥862.90k0.14%
CN¥ 5.0m
Xiangyu Li
Deputy General Manager8.9yrsCN¥763.90k0.12%
CN¥ 4.2m
Tao Ma
Deputy General Manager8.9yrsCN¥640.90k0.093%
CN¥ 3.3m
Hao Xiong
Accounting Supervisorno dataデータなしデータなし

8.9yrs

平均在職期間

48yo

平均年齢

経験豊富な経営陣: 688089の経営陣は経験豊富で経験豊富です(平均在職期間は8.9年)。


取締役

名称ポジション在職期間報酬所有権
Dewei Yi
Chairman & GM8.9yrsCN¥1.09m1.39%
CN¥ 48.4m
Huabiao Wang
Financial Director & Director8.9yrsCN¥781.40k0.66%
CN¥ 23.0m
Bin Du
Vice Chairman8.9yrsCN¥984.80k0.58%
CN¥ 20.3m
Yujun Wu
Employee Representative Supervisor8.9yrsデータなし0.018%
CN¥ 634.3k
Chunyu Zhang
Director2.9yrsデータなしデータなし
Xiangdong Chen
Independent Director2.9yrsCN¥80.00kデータなし
Qi Liu
Independent Director2.9yrsCN¥80.00kデータなし
Jing Chen
Supervisor2.9yrsデータなしデータなし

5.9yrs

平均在職期間

53.5yo

平均年齢

経験豊富なボード: 688089の 取締役会経験豊富 であると考えられます ( 5.9年の平均在任期間)。